Kytopen Analysis: $53M Raised
What is Kytopen?
Kytopen accelerates access to next-generation cell therapies through scalable genome engineering platforms. Their Flowfect technology enables efficient gene delivery across all development phases, addressing manufacturing challenges in cell therapy.
Location
750 Main St, Cambridge, Massachusetts 02139, United States
Employees
11-50
Founded
2017
Funding Status
Growth
Product Features & Capabilities
- Flowfect Discover platform for high-throughput transfections
- Flowfect TX platform for large-scale payload delivery
- Non-viral gene delivery solutions
- Automated liquid-handling systems
- Continuous flow transfection technology
Use Cases
Conduct high-throughput transfections for drug discovery; Scale gene delivery from small volumes to large manufacturing; Optimize transfection conditions for next-generation cell therapies; Deliver mRNA, DNA, and CRISPR Cas9 RNP to billions of cells; Integrate with standard liquid handling consumables
See something that needs updating? Suggest edits to this profile.